Ctrl K
OFF-2026-0002Novartis Pharma AGTMBE · EUR · v1
Offer Request
Net contract value
EUR 164,248
List EUR 164,248
Blended margin
62.2%
0%3045100%
Total effort
88 days
2 activities · 4 profiles
Cost & gross profit
EUR 102.2k
cost EUR 62,040 · GP EUR 102,208
Avg blended rate
EUR 1,866/d
across 4 profiles
Readiness & gates
Pricing
100%
Narrative
20%
Appr
TypeCountryCurrency EURFX rateDiscount %Rebate %
Presets
Days allocated per profile · click any cell to edit
Activity / Sub-activity
EC
🇧🇪
1,866 /day
cost €70562.2 %
PC
🇧🇪
1,965 /day
cost €908
PC
🇧🇪
1,965 /day
cost €908
PC
🇧🇪
1,965 /day
cost €908
Total
A01
164,248
62.2% margin
A02
0
margin
Profile totals
88 d
164,248
0 d
0
0 d
0
0 d
0
Net total
164,248
81000
qtydaysmk%81000
0

Scenarios — sensitivity

Revenue
€164,248
Cost
€62,040
GP €
€102,208
GP %
62.2%
ScenarioRevenueCostGP €GP %
Base€164,248€62,040€102,20862.2%

Scenarios are a what-if view (not saved). Rebate affects GP-after-rebate, not Revenue.

Allocation — estimated resources

ProfileEffort (d)Estimated headcount
EC · BE88
0.40
PC · BE0
0.00
PC · BE0
0.00
PC · BE0
0.00

Headcount = effort days ÷ working days. Maps to PQE staffing (Jasper) later.

Approval gates0 pendingAll gates pass
GP %
62.2%
OKPQE Mgmt
GP discount delta
Discount delta within tolerance
OKPQE Mgmt
Offer amount
EUR 245,248
Approval neededPQE VP
Subcontracting completeness
All subcontracting rows pass markup + verification
OKPQE VP
Offer validation0 blockingURS_OLM 1.17.2–1.17.6
All offer-integrity checks pass.